WASHINGTON (APRIL 5) – Dr. LaSalle D. Leffall, one of the world’s pre-eminent and highly regarded surgical oncologists and a Howard University icon, will chair of the board of directors of Susan G. Komen for the Cure®, the world’s largest breast cancer organization, for a second term.
Leffall, the Charles R. Drew professor of Surgery at Howard University College of Medicine and former chair of the Department of Surgery at Howard University Hospital and the College of Medicine, held the position previously from 2002 to 2007. He succeeds Alexine Clement Jackson as board chair and will serve for two years.
Leffall, who in his many years of service has taught two-thirds of all graduates from the College of Medicine, is one of the world’s leading medical educators and leader in professional and civic organizations. He is the current chair of the President’s Cancer Panel, a position he also held under former President George W. Bush.
Nancy G. Brinker, founder and CEO of Komen for the Cure and former U.S. ambassador to Hungary, praised Leffall for his skills and his leadership.
“Dr. Leffall is highly respected as an extraordinary surgeon, oncologist and educator who demonstrates each day his passion to end suffering from this disease,” Brinker said. “We value his demonstrated leadership ability in guiding our family of staff, volunteers, grantees, partners and advocates around the world, and we know that under his leadership once again, Komen will move closer to discovering and delivering the cures for breast cancer.”
Leffall said one of the greatest gifts that Komen gives people around the world facing breast cancer is hope.